JoVE Logo
Faculty Resource Center

Sign In

Determinare la frequenza inibitorio ottimale per le cellule cancerose del tumore Uso Trattare Fields (TTFields)

14.2K Views

08:14 min

May 4th, 2017

DOI :

10.3791/55820-v

May 4th, 2017

14,245 Views

1Preclinical Research Department, Novocure Ltd., Haifa, Israel, 2Novocure Ltd., Haifa, Israel, 3Novocure GmbH, Lucerne, Switzerland

Transcript

Explore More Videos

Cancer Research
JoVE Logo

Privacy

Terms of Use

Policies

Research

Education

ABOUT JoVE

Copyright © 2024 MyJoVE Corporation. All rights reserved